Protective Effects of Cariporide on Endothelial Dysfunction Induced by Homocysteine

被引:13
作者
Wu, Shujin [1 ,3 ]
Gao, Xiang [1 ]
Yang, Shehua [1 ]
Liu, Liying [3 ]
Ge, Bin [1 ]
Yang, Qingshan [2 ]
机构
[1] Gan Su Prov Hosp, Dept Pharm, Lanzhou 730000, Gansu, Peoples R China
[2] Gan Su Prov Hosp, Dept Orthopaed, Lanzhou 730000, Gansu, Peoples R China
[3] Cent S Univ, Pharmaceut Coll, Dept Pharmacol, Changsha, Hunan, Peoples R China
关键词
Homocysteine; Cariporide; Endothelial dysfunction; Oxidative stress; Nuclear factor-kappa B; NA+/H+ EXCHANGER; CARDIOVASCULAR-DISEASE;
D O I
10.1159/000356318
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims: Recent studies have reported that intracellular calcium (Ca2+) mobilization is involved in homocysteine (Hcy)-induced endothelial dysfunction and the Na+/H+ exchanger (NHE) is responsible for an increase in the intracellular Ca2+ concentration in cardiovascular disease. We hypothesized that inhibition of the NHE had protective effects on Hcy-induced endothelial dysfunction. Methods: Acetylcholine-induced endothelium-dependent relaxation (EDR) and biochemical parameters were measured in the rat isolated aorta. The level of reactive oxygen species (ROS) was designed by a specific fluorescent probe. The phosphorylation of the nuclear factor-kappa B (NF-kappa B) system was studied by Western blot. Results: Cariporide significantly prevented Hcy-impaired EDR and increased nitric oxide (NO) release; endothelial NO synthase activity simultaneously decreased ROS production. We also found that cariporide blocked Hcy-induced NE-kappa B activation and inhibitor-kappa B degradation, thus inhibiting the production of tumor necrosis factor-alpha and intercellular adhesion molecule-1. Conclusions:The mechanisms of protective effects of cariporide may be related to the inhibition of NHE and the decrease in oxidative stress and inflammatory injury. (C) 2013 S. Karger AG, Basel
引用
收藏
页码:303 / 309
页数:7
相关论文
共 22 条
[1]   Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus [J].
Alexandru, N. ;
Jardin, I. ;
Popov, D. ;
Simionescu, M. ;
Garcia-Estan, J. ;
Salido, G. M. ;
Rosado, J. A. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (5B) :2015-2026
[2]   Folate, homocysteine, endothelial function and cardiovascular disease. What is the link? [J].
Ashfield-Watt, PAL ;
Moat, SJ ;
Doshi, SN ;
McDowell, IFW .
BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (08) :425-433
[3]   Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries [J].
Chen, CY ;
Conklin, BS ;
Ren, Z ;
Zhong, DS .
JOURNAL OF SURGICAL RESEARCH, 2002, 102 (01) :22-30
[4]  
Finch Jennifer M., 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P241
[5]   NHE and ICAM-1 expression in hypoxic/reoxygenated coronary microvascular endothelial cells [J].
Hattori, R ;
Otani, H ;
Moriguchi, Y ;
Matsubara, H ;
Yamamura, T ;
Nakao, Y ;
Omiya, H ;
Osako, M ;
Imamura, H .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (06) :H2796-H2803
[6]   Homocysteine as a Risk Factor for Cardiovascular Disease in Patients Treated by Dialysis: A Meta-analysis [J].
Heinz, Judith ;
Kropf, Siegfried ;
Luley, Claus ;
Dierkes, Jutta .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (03) :478-489
[7]  
Jacobsen DW, 1998, CLIN CHEM, V44, P1833
[8]   Intracellular pH regulation by Na+/H+ exchanger-1 (NHE1) is required for growth factor-induced mammary branching morphogenesis [J].
Jenkins, Edmund C., Jr. ;
Debnath, Shawon ;
Gundry, Stephen ;
Gundry, Sajini ;
Uyar, Umit ;
Fata, Jimmie E. .
DEVELOPMENTAL BIOLOGY, 2012, 365 (01) :71-81
[9]   Mechanism of Action of Homocysteine and Its Thiolactone in Hemostasis System [J].
Karolczak, K. ;
Olas, B. .
PHYSIOLOGICAL RESEARCH, 2009, 58 (05) :623-633
[10]   Homocysteine and cardiovascular disease: Current evidence and future prospects [J].
Mangoni, AA ;
Jackson, SHD .
AMERICAN JOURNAL OF MEDICINE, 2002, 112 (07) :556-565